{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:44:03Z","timestamp":1792511043882,"version":"4.5.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:00:00Z","timestamp":1792454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:00:00Z","timestamp":1792454400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Addict Sci Clin Pract"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Wernicke encephalopathy (WE) is a potentially reversible neurological emergency that remains frequently missed and undertreated in patients with alcohol use disorder (AUD). Although thiamine is widely accepted as the cornerstone of prevention and treatment, diagnostic uncertainty, limited comparative evidence, and heterogeneous clinical recommendations contribute to substantial variability in real-world management. This scoping review aimed to map the available evidence on the diagnosis and clinical management of WE in patients with AUD or clinically significant alcohol use, with particular attention to practice variability, undertreatment, and clinically actionable gaps in care.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a scoping review in accordance with PRISMA-ScR guidance. Electronic databases and trial registries were searched for studies addressing the diagnosis, prevention, or treatment of WE in populations with AUD or clinically significant alcohol use. Eligible sources included randomized controlled trials, observational studies, clinical audits, and implementation-focused reports. Data were charted and synthesized thematically.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 26 studies were included. The evidence base was limited and heterogeneous. Only two randomized controlled trials evaluated thiamine regimens, and no consensus emerged regarding optimal dosing. Diagnostic criteria for WE varied widely across studies, with inconsistent use of formal criteria such as the Caine criteria. Across observational studies and prescribing audits, undertreatment was consistently reported, including delayed initiation of therapy and frequent use of oral thiamine in high-risk scenarios. Studies describing more protocolized and guideline-concordant care more often reported earlier treatment initiation and use of parenteral thiamine in suspected or confirmed cases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>WE remains underrecognized and undertreated in AUD and clinically significant alcohol use. The mapped evidence suggests that diagnostic uncertainty, limited trial data, and inconsistent implementation of recommendations are associated with persistent variability in care. Although the optimal thiamine regimen remains unresolved, early recognition and appropriate parenteral treatment in high-risk or suspected cases represent actionable opportunities to reduce preventable neurological morbidity.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13722-026-00687-x","type":"journal-article","created":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T02:48:32Z","timestamp":1792464512000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Undertreatment of Wernicke encephalopathy in alcohol-related clinical contexts: a scoping review of diagnosis, thiamine regimens, and clinical management"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3210-0968","authenticated-orcid":false,"given":"Andr\u00e9 Akira Sueno","family":"Goldani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-9901-0374","authenticated-orcid":false,"given":"Gabriel","family":"Feitosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-9872-0955","authenticated-orcid":false,"given":"Eduarda Vasconcelos","family":"Colchete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6767-362X","authenticated-orcid":false,"given":"Cristhian Ferreira","family":"Falleiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-9400-9192","authenticated-orcid":false,"given":"Cristine Weihrauch","family":"Pedro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7059-2564","authenticated-orcid":false,"given":"F\u00e9lix Henrique Paim","family":"Kessler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3555-5228","authenticated-orcid":false,"given":"Thiago M.","family":"Fidalgo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9228-7114","authenticated-orcid":false,"given":"Lisia","family":"von Diemen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,20]]},"reference":[{"key":"687_CR1","unstructured":"World Health Organization. Global status report on alcohol and health 2018. 2018. Geneva: World Health Organization. Available from: https:\/\/iris.who.int\/handle\/10665\/274603."},{"issue":"2","key":"687_CR2","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s11065-012-9196-z","volume":"22","author":"AD Thomson","year":"2012","unstructured":"Thomson AD, Guerrini I, Marshall EJ. The evolution and treatment of Korsakoff\u2019s syndrome: out of sight, out of mind? Neuropsychol Rev. 2012;22(2):81\u201392. https:\/\/doi.org\/10.1007\/s11065-012-9196-z.","journal-title":"Neuropsychol Rev"},{"issue":"5","key":"687_CR3","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/S1474-4422(07)70104-7","volume":"6","author":"G Sechi","year":"2007","unstructured":"Sechi G, Serra A. Wernicke\u2019s encephalopathy: new clinical settings and recent advances in diagnosis and management. Lancet Neurol. 2007;6(5):442\u201355. https:\/\/doi.org\/10.1016\/S1474-4422(07)70104-7.","journal-title":"The Lancet Neurol"},{"issue":"2","key":"687_CR4","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1093\/alcalc\/agn120","volume":"44","author":"AS Hazell","year":"2009","unstructured":"Hazell AS, Butterworth RF. Update of cell damage mechanisms in thiamine deficiency: focus on oxidative stress, excitotoxicity and inflammation. Alcohol Alcohol. 2009;44(2):141\u201347. https:\/\/doi.org\/10.1093\/alcalc\/agn120.","journal-title":"Alcohol Alcohol"},{"issue":"5","key":"687_CR5","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1093\/oxfordjournals.alcalc.a008184","volume":"31","author":"HK Rooprai","year":"1996","unstructured":"Rooprai HK, Pratt OE, Shaw GK, Thomson AD. Thiamine pyrophosphate effect and normalized erythrocyte transketolase activity ratio in Wernicke-Korsakoff patients and acute alcoholics undergoing detoxification. Alcohol Alcohol. 1996;31(5):493\u2013501. https:\/\/doi.org\/10.1093\/oxfordjournals.alcalc.a008184.","journal-title":"Alcohol Alcohol"},{"issue":"4","key":"687_CR6","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1136\/jnnp.49.4.341","volume":"49","author":"CG Harper","year":"1986","unstructured":"Harper CG, Giles M, Finlay-Jones R. Clinical signs in the Wernicke-Korsakoff complex: a retrospective analysis of 131 cases diagnosed at necropsy. J Neurol Neurosurg Psychiatry. 1986;49(4):341\u201345. https:\/\/doi.org\/10.1136\/jnnp.49.4.341.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"687_CR7","doi-asserted-by":"publisher","unstructured":"Puertas-Miranda D, D\u00edaz-Avila EG, Llamas-Alonso C, Novo-Veleiro I, Chamorro AJ, Marcos M. Alcohol-related and non-alcohol-related Wernicke encephalopathy: a systematic review and meta-analysis of epidemiology and clinical features. Neuroepidemiology. 2025:1\u201317. https:\/\/doi.org\/10.1159\/000547806. Epub ahead of print.","DOI":"10.1159\/000547806"},{"key":"687_CR8","volume-title":"The Wernicke-Korsakoff syndrome and related neurologic disorders due to alcoholism and malnutrition","author":"M Victor","year":"1989","unstructured":"Victor M, Adams RD, Collins GH. The Wernicke-Korsakoff syndrome and related neurologic disorders due to alcoholism and malnutrition. 2nd. Philadelphia: F.A. Davis Co; 1989.","edition":"2nd"},{"issue":"1","key":"687_CR9","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3174\/ajnr.A1280","volume":"30","author":"G Zuccoli","year":"2009","unstructured":"Zuccoli G, Santa Cruz D, Bertolini M, Rovira A, Gallucci M, Carollo C, et al. MR imaging findings in 56 patients with Wernicke encephalopathy: nonalcoholics may differ from alcoholics. AJNR Am J Neuroradiol. 2009, Jan;30(1):171\u201376. https:\/\/doi.org\/10.3174\/ajnr.A1280. Epub 2008 Oct 22. PMID: 18945789; PMCID: PMC7051709.","journal-title":"AJNR Am J Neuroradiol"},{"issue":"1","key":"687_CR10","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1136\/jnnp.62.1.51","volume":"62","author":"D Caine","year":"1997","unstructured":"Caine D, Halliday GM, Kril JJ, Harper CG. Operational criteria for the classification of chronic alcoholics: identification of Wernicke\u2019s encephalopathy. J Neurol Neurosurg Psychiatry. 1997;62(1):51\u201360. https:\/\/doi.org\/10.1136\/jnnp.62.1.51.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"687_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/01.ADM.0000435320.72857.c8","volume":"8","author":"E Isenberg-Grzeda","year":"2014","unstructured":"Isenberg-Grzeda E, Chabon B, Nicolson SE. Prescribing thiamine to inpatients with alcohol use disorders: how well are we doing? J Addict Med. 2014;8(1):1\u20135. https:\/\/doi.org\/10.1097\/01.ADM.0000435320.72857.c8.","journal-title":"J Addict Med"},{"issue":"6","key":"687_CR12","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1080\/00952990.2021.1889575","volume":"47","author":"NM Peck","year":"2021","unstructured":"Peck NM, Bania TC, Chu J. Low rates of thiamine prescribing in adult patients with alcohol-related diagnoses in the emergency department. Am J Drug Alcohol Abuse. 2021;47(6):704\u201310. https:\/\/doi.org\/10.1080\/00952990.2021.1889575.","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"5","key":"687_CR13","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1097\/00005053-193911000-00001","volume":"90","author":"KM Bowman","year":"1939","unstructured":"Bowman KM, Goodhart R, Jolliffe N. Observations on the role of vitamin B1 in the etiology and treatment of Korsakoff psychosis. J Nerv Ment Dis. 1939;90(5):569\u201375. https:\/\/doi.org\/10.1097\/00005053-193911000-00001.","journal-title":"J Nerv Ment Dis"},{"issue":"6","key":"687_CR14","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1093\/alcalc\/37.6.513","volume":"37","author":"AD Thomson","year":"2002","unstructured":"Thomson AD, Cook CCH, Touquet R, Henry JA. The Royal College of Physicians report on alcohol: guidelines for managing Wernicke\u2019s encephalopathy in the accident and emergency department. Alcohol Alcohol. 2002;37(6):513\u201321. https:\/\/doi.org\/10.1093\/alcalc\/37.6.513.","journal-title":"Alcohol Alcohol"},{"issue":"3","key":"687_CR15","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1159\/000499039","volume":"25","author":"N Pruckner","year":"2019","unstructured":"Pruckner N, Baumgartner J, Hinterbuchinger B, Glahn A, Vyssoki S, Vyssoki B. Thiamine substitution in alcohol use disorder: a narrative review of medical guidelines. Eur Addict Res. 2019;25(3):103\u201310. https:\/\/doi.org\/10.1159\/000499039.","journal-title":"Eur Addict Res"},{"issue":"1","key":"687_CR16","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/nyas.14536","volume":"1498","author":"TJ Smith","year":"2021","unstructured":"Smith TJ, Johnson CR, Koshy R, Hess SY, Qureshi UA, Mynak ML, et al. Thiamine deficiency disorders: a clinical perspective. Ann N Y Acad Sci. 2021;1498(1):9\u201328. https:\/\/doi.org\/10.1111\/nyas.14536.","journal-title":"Ann N Y Acad Sci"},{"issue":"7","key":"687_CR17","doi-asserted-by":"publisher","first-page":"CD004033","DOI":"10.1002\/14651858.CD004033.pub3","volume":"2013","author":"E Day","year":"2013","unstructured":"Day E, Bentham PW, Callaghan R, Kuruvilla T, George S. Thiamine for prevention and treatment of Wernicke-Korsakoff syndrome in people who abuse alcohol. Cochrane Database Syst Rev. 2013;2013(7):CD004033. https:\/\/doi.org\/10.1002\/14651858.CD004033.pub3.","journal-title":"Cochrane Database Syst Rev"},{"key":"687_CR18","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.genhosppsych.2024.01.005","volume":"87","author":"A Cantu-Weinstein","year":"2024","unstructured":"Cantu-Weinstein A, Branning R, Alamir M, Weleff J, Do M, Nero N, et al. Diagnosis and treatment of Wernicke\u2019s encephalopathy: a systematic literature review. Gener Hosp Psychiatry. 2024;87:48\u201359. https:\/\/doi.org\/10.1016\/j.genhosppsych.2024.01.005.","journal-title":"Gener Hosp Psychiatry"},{"issue":"7","key":"687_CR19","doi-asserted-by":"publisher","first-page":"467","DOI":"10.7326\/M18-0850","volume":"169","author":"AC Tricco","year":"2018","unstructured":"Tricco AC, Lillie E, Zarin W, O\u2019Brien KK, Colquhoun H, Levac D, et al. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018;169(7):467\u201373. https:\/\/doi.org\/10.7326\/M18-0850.","journal-title":"Ann Intern Med"},{"key":"687_CR20","doi-asserted-by":"publisher","first-page":"i4919","DOI":"10.1136\/bmj.i4919","volume":"355","author":"JA Sterne","year":"2016","unstructured":"Sterne JA, Hern\u00e1n MA, Reeves BC, Savovi\u0107 J, Berkman ND, Viswanathan M, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355:i4919. https:\/\/doi.org\/10.1136\/bmj.i4919.","journal-title":"BMJ"},{"key":"687_CR21","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","volume":"366","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898. https:\/\/doi.org\/10.1136\/bmj.l4898.","journal-title":"BMJ"},{"key":"687_CR22","unstructured":"Wells GA, Shea B, O\u2019Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2013. Ottawa. Ottawa Hospital Research Institute. Available from: https:\/\/ohri.ca\/en\/who-we-are\/core-facilities-and-platforms\/ottawa-methods-centre\/newcastle-ottawa-scale."},{"key":"687_CR23","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. https:\/\/doi.org\/10.1136\/bmj.n71.","journal-title":"BMJ"},{"issue":"28","key":"687_CR24","first-page":"2054","volume":"172","author":"L Damsgaard","year":"2010","unstructured":"Damsgaard L, Ulrichsen J, Nielsen MK. Wernickes encefalopati hos patienter med alkoholabstinenssymptomer. Ugeskr L\u00e6ger. 2010;172(28):2054\u201358.","journal-title":"Ugeskr L\u00e6ger"},{"issue":"Suppl","key":"687_CR25","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3177\/jnsv.22.supplement_63","volume":"22","author":"H Baker","year":"1976","unstructured":"Baker H, Frank O. Absorption, utilization and clinical effectiveness of allithiamines compared to water-soluble thiamines. J Nutr Sci Vitaminol (Tokyo). 1976;22(Suppl):63\u201368. https:\/\/doi.org\/10.3177\/jnsv.22.supplement_63.","journal-title":"J Nutr Sci Vitaminol (Tokyo)"},{"issue":"6","key":"687_CR26","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1111\/acer.14843","volume":"46","author":"KM Dingwall","year":"2022","unstructured":"Dingwall KM, Delima JF, Binks P, Batey R, Bowden SC. What is the optimum thiamine dose to treat or prevent Wernicke\u2019s encephalopathy or Wernicke\u2013Korsakoff syndrome? Results of a randomized controlled trial. Alcohol Clin Exp Res. 2022;46(6):1133\u201347. https:\/\/doi.org\/10.1111\/acer.14843.","journal-title":"Alcohol Clin Exp Res"},{"issue":"1","key":"687_CR27","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.psym.2019.08.002","volume":"61","author":"S Lin","year":"2020","unstructured":"Lin S, Leppla IE, Yan H, Probert JM, Randhawa PA, Leoutsakos J-M, et al. Prevalence and improvement of Caine-positive Wernicke-Korsakoff syndrome in psychiatric inpatient admissions. Psychosomatics. 2020;61(1):31\u201338. https:\/\/doi.org\/10.1016\/j.psym.2019.08.002.","journal-title":"Psychosomatics"},{"issue":"1","key":"687_CR28","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.clnu.2021.10.021","volume":"41","author":"F Mifsud","year":"2022","unstructured":"Mifsud F, Messager D, Jannot AS, V\u00e9die B, Balanant NA, Poghosyan T, et al. Clinical diagnosis, outcomes and treatment of thiamine deficiency in a tertiary hospital. Clin Nutr. 2022;41(1):33\u201339. https:\/\/doi.org\/10.1016\/j.clnu.2021.10.021.","journal-title":"Clin Nutr"},{"issue":"2","key":"687_CR29","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1007\/s10072-022-06477-y","volume":"44","author":"AR Silva","year":"2023","unstructured":"Silva AR, Almeida-Xavier S, Lopes M, Soares-Fernandes JP, Sousa F, Varanda S. Is there a time window for MRI in Wernicke encephalopathy \u2014 a decade of experience from a tertiary hospital. Neurol Sci. 2023;44(2):703\u201308. https:\/\/doi.org\/10.1007\/s10072-022-06477-y.","journal-title":"Neurol Sci"},{"issue":"5","key":"687_CR30","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1111\/j.1445-5994.1977.tb03368.x","volume":"7","author":"B Wood","year":"1977","unstructured":"Wood B, Breen KJ, Penington DG. Thiamine status in alcoholism. Aust N Z J Med. 1977;7(5):475\u201384. https:\/\/doi.org\/10.1111\/j.1445-5994.1977.tb03368.x.","journal-title":"Aust N Z J Med"},{"key":"687_CR31","doi-asserted-by":"publisher","first-page":"209485","DOI":"10.1016\/j.josat.2024.209485","volume":"166","author":"SW Baron","year":"2024","unstructured":"Baron SW, Wai JM, Aloezos C, Cregin R, Ceresnak J, Dekhtyar J, et al. Improving thiamine prescribing in alcohol use disorder using electronic decision support in a large urban academic medical center: a pre-post intervention study. J Subst Use Addict Treat. 2024;166:209485. https:\/\/doi.org\/10.1016\/j.josat.2024.209485.","journal-title":"J Subst Use Addict Treat"},{"issue":"2","key":"687_CR32","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1503\/cjs.020112","volume":"57","author":"C Blackmore","year":"2014","unstructured":"Blackmore C, Ouellet J-F, Niven D, Kirkpatrick AW, Ball CG. Prevention of delirium in trauma patients: are we giving thiamine prophylaxis a fair chance? Can J Surg. 2014;57(2):78\u201381. https:\/\/doi.org\/10.1503\/cjs.020112.","journal-title":"Can J Surg"},{"issue":"3","key":"687_CR33","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1192\/pb.29.3.94","volume":"29","author":"C McIntosh","year":"2005","unstructured":"McIntosh C, Kippen V, Hutcheson F, McIntosh A. Parenteral thiamine use in the prevention and treatment of Wernicke\u2013Korsakoff syndrome. Psychiatr Bull. 2005;29(3):94\u201397. https:\/\/doi.org\/10.1192\/pb.29.3.94.","journal-title":"Psychiatr Bull"},{"issue":"1","key":"687_CR34","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1093\/alcalc\/ags120","volume":"48","author":"E Rees","year":"2013","unstructured":"Rees E, Gowing LR. Supplementary thiamine is still important in alcohol dependence. Alcohol Alcohol. 2013;48(1):88\u201392. https:\/\/doi.org\/10.1093\/alcalc\/ags120.","journal-title":"Alcohol Alcohol"},{"issue":"3","key":"687_CR35","doi-asserted-by":"publisher","first-page":"e61","DOI":"10.1192\/bjo.2023.45","volume":"9","author":"J Sinclair","year":"2023","unstructured":"Sinclair J, Barnes TRE, Lingford-Hughes A, Drummond C, Loubser I, Rendora O, et al. Management of medically assisted withdrawal from alcohol in acute adult mental health and specialist addictions in-patient services: UK clinical audit findings. BJPsych Open. 2023;9(3):e61. https:\/\/doi.org\/10.1192\/bjo.2023.45.","journal-title":"BJPsych Open"},{"issue":"1","key":"687_CR36","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1177\/1078345810385913","volume":"17","author":"PA Talbot","year":"2011","unstructured":"Talbot PA. Timing of efficacy of thiamine in Wernicke\u2019s disease in alcoholics at risk. J Correct Health Care. 2011;17(1):46\u201350. https:\/\/doi.org\/10.1177\/1078345810385913.","journal-title":"J Correct Health Care"},{"key":"687_CR37","doi-asserted-by":"publisher","first-page":"110961","DOI":"10.1016\/j.drugalcdep.2023.110961","volume":"252","author":"I Novo-Veleiro","year":"2023","unstructured":"Novo-Veleiro I, Mateos-D\u00edaz A-M, Ros\u00f3n-Hern\u00e1ndez B, Medina-Garc\u00eda J-A, Muga R, Fern\u00e1ndez-Sol\u00e1 J, et al. Treatment variability and its relationships to outcomes among patients with Wernicke\u2019s encephalopathy: a multicenter retrospective study. Drug Alcohol Depend. 2023;252:110961. https:\/\/doi.org\/10.1016\/j.drugalcdep.2023.110961.","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"687_CR38","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.therap.2019.09.001","volume":"75","author":"L Collet","year":"2020","unstructured":"Collet L, Bisch M, Viennet S, Schwan R, Paille F. Thiamine et trouble de l\u2019usage d\u2019alcool: une enqu\u00eate de pratique nationale [Thiamine and alcohol use disorder: a national survey of practice]. Therapie. 2020;75(3):281\u201394. https:\/\/doi.org\/10.1016\/j.therap.2019.09.001.","journal-title":"Therapie"},{"issue":"4","key":"687_CR39","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1002\/jhm.2324","volume":"10","author":"GS Day","year":"2015","unstructured":"Day GS, Ladak S, Curley K, Farb NAS, Masiowski P, Pringsheim T, et al. Thiamine prescribing practices within university-affiliated hospitals: a multicenter retrospective review. J Hosp Med. 2015;10(4):246\u201353. https:\/\/doi.org\/10.1002\/jhm.2324.","journal-title":"J Hosp Med"},{"issue":"Suppl 1","key":"687_CR40","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/alcalc\/35.supplement_1.16","volume":"35","author":"RK Ferguson","year":"2000","unstructured":"Ferguson RK, Soryal IN, Pentland B. Wernicke-Korsakoff syndrome in head injury: a missed insult. Alcohol Alcohol. 2000;35(Suppl 1):16\u201318. https:\/\/doi.org\/10.1093\/alcalc\/35.supplement_1.16.","journal-title":"Alcohol Alcohol"},{"key":"687_CR41","doi-asserted-by":"publisher","unstructured":"Guirguis M, Manning S, Chavez M, Nelson J, Baronia R, Bobba S, et al. Are psychiatric inpatients at risk of developing Wernicke\u2019s encephalopathy being identified and adequately treated? Prim Care Companion CNS Disord. 2017;19(6):17m02179. https:\/\/doi.org\/10.4088\/PCC.17m02179.","DOI":"10.4088\/PCC.17m02179"},{"issue":"5","key":"687_CR42","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1097\/PRA.0000000000000326","volume":"24","author":"LM Linder","year":"2018","unstructured":"Linder LM, Robert S, Mullinax K, Hayes G. Thiamine prescribing and Wernicke\u2019s encephalopathy risk factors in patients with alcohol use disorders at a psychiatric hospital. J Psychiatr Pract. 2018;24(5):317\u201322. https:\/\/doi.org\/10.1097\/PRA.0000000000000326.","journal-title":"J Psychiatr Pract"},{"issue":"4","key":"687_CR43","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.psym.2018.01.004","volume":"59","author":"ZM Nakamura","year":"2018","unstructured":"Nakamura ZM, Tatreau JR, Rosenstein DL, Park EM. Clinical characteristics and outcomes associated with high-dose intravenous thiamine administration in patients with encephalopathy. Psychosomatics. 2018;59(4):379\u201387. https:\/\/doi.org\/10.1016\/j.psym.2018.01.004.","journal-title":"Psychosomatics"},{"issue":"3","key":"687_CR44","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1093\/oxfordjournals.alcalc.a008268","volume":"32","author":"A Ramayya","year":"1997","unstructured":"Ramayya A, Jauhar P. Increasing incidence of Korsakoff\u2019s psychosis in the east end of Glasgow. Alcohol Alcohol. 1997;32(3):281\u201385. https:\/\/doi.org\/10.1093\/oxfordjournals.alcalc.a008268.","journal-title":"Alcohol Alcohol"},{"issue":"1","key":"687_CR45","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1111\/j.1530-0277.2001.tb02134.x","volume":"25","author":"ML Ambrose","year":"2001","unstructured":"Ambrose ML, Bowden SC, Whelan G. Thiamin treatment and working memory function of alcohol-dependent people: preliminary findings. Alcohol Clin Exp Res. 2001;25(1):112\u201316. https:\/\/doi.org\/10.1111\/j.1530-0277.2001.tb02134.x.","journal-title":"Alcohol Clin Exp Res"},{"issue":"7","key":"687_CR46","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1080\/1028415X.2019.1652438","volume":"24","author":"L Coulbault","year":"2021","unstructured":"Coulbault L, Ritz L, Vabret F, Lannuzel C, Boudehent C, Nowoczyn M, et al. Thiamine and phosphate esters concentrations in whole blood and serum of patients with alcohol use disorder: a relation with cognitive deficits. Nutr Neurosci. 2021;24(7):530\u201341. https:\/\/doi.org\/10.1080\/1028415X.2019.1652438.","journal-title":"Nutr Neurosci"},{"issue":"3","key":"687_CR47","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1093\/alcalc\/agh051","volume":"39","author":"X Sgouros","year":"2004","unstructured":"Sgouros X, Baines M, Bloor RN, McAuley R, Ogundipe LO, Willmott S. Evaluation of a clinical screening instrument to identify states of thiamine deficiency in inpatients with severe alcohol dependence syndrome. Alcohol Alcohol. 2004;39(3):227\u201332. https:\/\/doi.org\/10.1093\/alcalc\/agh051.","journal-title":"Alcohol Alcohol"},{"issue":"2","key":"687_CR48","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1111\/j.1530-0277.1992.tb01384.x","volume":"16","author":"CME Tallaksen","year":"1992","unstructured":"Tallaksen CME, B\u00f8hmer T, Bell H. Blood and serum thiamin and thiamin phosphate esters concentrations in patients with alcohol dependence syndrome before and after thiamin treatment. Alcohol Clin Exp Res. 1992;16(2):320\u201325. https:\/\/doi.org\/10.1111\/j.1530-0277.1992.tb01384.x.","journal-title":"Alcohol Clin Exp Res"},{"issue":"9","key":"687_CR49","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.medcli.2021.11.015","volume":"158","author":"A-M Mateos-D\u00edaz","year":"2022","unstructured":"Mateos-D\u00edaz A-M, Marcos M, Chamorro A-J. S\u00edndrome de Wernicke-Korsakoff y otras patolog\u00edas asociadas al d\u00e9ficit de tiamina. Medicina Cl\u00ednica. 2022;158(9):431\u201336. https:\/\/doi.org\/10.1016\/j.medcli.2021.11.015.","journal-title":"Medicina Cl\u00ednica"},{"issue":"10","key":"687_CR50","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1111\/j.1468-1331.2006.01530.x","volume":"13","author":"C Harper","year":"2006","unstructured":"Harper C. Thiamine (vitamin B1) deficiency and associated brain damage is still common throughout the world and prevention is simple and safe! Eur J Neurol. 2006;13(10):1078\u201382. https:\/\/doi.org\/10.1111\/j.1468-1331.2006.01530.x.","journal-title":"Eur J Neurol"},{"issue":"2","key":"687_CR51","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1093\/alcalc\/agh249","volume":"41","author":"AD Thomson","year":"2006","unstructured":"Thomson AD, Marshall EJ. The natural history and pathophysiology of Wernicke\u2019s encephalopathy and Korsakoff\u2019s psychosis. Alcohol Alcohol. 2006;41(2):151\u201358. https:\/\/doi.org\/10.1093\/alcalc\/agh249.","journal-title":"Alcohol Alcohol"},{"issue":"2","key":"687_CR52","doi-asserted-by":"publisher","first-page":"273","DOI":"10.3109\/00365528109181968","volume":"16","author":"ME Camilo","year":"1981","unstructured":"Camilo ME, Morgan MY, Sherlock S. Erythrocyte transketolase activity in alcoholic liver disease. Scand J Gastroenterol. 1981;16(2):273\u201379. https:\/\/doi.org\/10.3109\/00365528109181968.","journal-title":"Scand J Gastroenterol"},{"issue":"5","key":"687_CR53","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1093\/alcalc\/agac032","volume":"57","author":"NL O\u2019Brien","year":"2022","unstructured":"O\u2019Brien NL, Quadri G, Lightley I, Sharp SI, Guerrini I, Smith I, et al. SLC19A1 genetic variation leads to altered thiamine diphosphate transport: implications for the risk of developing Wernicke\u2013Korsakoff\u2019s syndrome. Alcohol Alcohol. 2022, Sep, 10;57(5):581\u201388. https:\/\/doi.org\/10.1093\/alcalc\/agac032. PMID: 35952336.","journal-title":"Alcohol Alcohol"},{"issue":"2","key":"687_CR54","first-page":"134","volume":"27","author":"PR Martin","year":"2003","unstructured":"Martin PR, Singleton CK, Hiller-Sturmh\u00f6fel S. The role of thiamine deficiency in alcoholic brain disease. Alcohol Res Health. 2003;27(2):134\u201342.","journal-title":"Alcohol Res Health"},{"issue":"1","key":"687_CR55","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/nyas.13919","volume":"1430","author":"KC Whitfield","year":"2018","unstructured":"Whitfield KC, Bourassa MW, Adamolekun B, Bergeron G, Bettendorff L, Brown KH, et al. Thiamine deficiency disorders: diagnosis, prevalence, and a roadmap for global control programs. Ann N Y Acad Sci. 2018;1430(1):3\u201343. https:\/\/doi.org\/10.1111\/nyas.13919.","journal-title":"Ann N Y Acad Sci"},{"issue":"26","key":"687_CR56","first-page":"1740","volume":"1","author":"S Meier","year":"2005","unstructured":"Meier S, Daeppen JB. Prevalence, prophylaxis and treatment of Wernicke encephalopathy. Thiamine, how much and how do we give it? Rev Med Suisse. 2005;1(26):1740\u201344.","journal-title":"Rev Med Suisse"},{"issue":"6","key":"687_CR57","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1093\/alcalc\/agy091","volume":"54","author":"A Thomson","year":"2019","unstructured":"Thomson A, Guerrini I, Marshall EJ. Incidence of adverse reactions to parenteral thiamine in the treatment of Wernicke\u2019s encephalopathy, and recommendations. Alcohol Alcohol. 2019;54(6):609\u201314. https:\/\/doi.org\/10.1093\/alcalc\/agy091.","journal-title":"Alcohol Alcohol"},{"issue":"7","key":"687_CR58","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1136\/jnnp.46.7.593","volume":"46","author":"C Harper","year":"1983","unstructured":"Harper C. The incidence of Wernicke\u2019s encephalopathy in Australia--a neuropathological study of 131 cases. J Neurol Neurosurg Psychiatry. 1983;46(7):593\u201398. https:\/\/doi.org\/10.1136\/jnnp.46.7.593.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"687_CR59","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1093\/alcalc\/agad017","volume":"58","author":"S Listabarth","year":"2023","unstructured":"Listabarth S, Vyssoki B, Marculescu R, Gleiss A, Groemer M, Trojer A, et al. Can thiamine substitution restore cognitive function in alcohol use disorder? Alcohol Alcohol. 2023;58(3):315\u201323. https:\/\/doi.org\/10.1093\/alcalc\/agad017.","journal-title":"Alcohol Alcohol"},{"key":"687_CR60","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.ejim.2025.01.008","volume":"134","author":"J Teixeira","year":"2025","unstructured":"Teixeira J, Pereira I, Castanho M, Couto F. What is the impact of thiamine deficiency on cognitive function in patients with alcohol use disorder? \u2013 a systematic review. Eur J Intern Med. 2025;134:59\u201365. https:\/\/doi.org\/10.1016\/j.ejim.2025.01.008.","journal-title":"Eur J Intern Med"},{"issue":"12","key":"687_CR61","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1111\/j.1468-1331.2010.03153.x","volume":"17","author":"R Galvin","year":"2010","unstructured":"Galvin R, Br\u00e5then G, Ivashynka A, Hillbom M, Tanasescu R, Leone MA. EFNS guidelines for diagnosis, therapy and prevention of Wernicke encephalopathy. Eur J Neurol. 2010;17(12):1408\u201318. https:\/\/doi.org\/10.1111\/j.1468-1331.2010.03153.x.","journal-title":"Eur J Neurol"}],"container-title":["Addiction Science &amp; Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13722-026-00687-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13722-026-00687-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13722-026-00687-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:02:02Z","timestamp":1792508522000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13722-026-00687-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,20]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["687"],"URL":"https:\/\/doi.org\/10.1186\/s13722-026-00687-x","relation":{},"ISSN":["1940-0640"],"issn-type":[{"value":"1940-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,20]]},"assertion":[{"value":"17 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"During the preparation of this manuscript, the authors used ChatGPT (OpenAI) exclusively for language editing and style improvement. The tool was not used to generate or modify scientific content, interpret data, perform analyses, determine eligibility, extract data, or make methodological decisions. The authors reviewed and edited all text and take full responsibility for the accuracy and integrity of the work.","order":3,"name":"Ethics","label":"Generative AI and AI-assisted technologies in the manuscript preparation process","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"80"}}